The assessment of pharmaceutical care of patients with cardiovascular diseases by the results of frequency analysis of drug prescribing
Keywords:cardiovascular diseases, pharmaceutical care, acetylsalicylic acid, frequency analysis
Aim. To assess the state of pharmaceutical care of patients with cardiovascular diseases (CVD) based on the results of frequency analysis.
Materials and methods. In the course of the study the cards of patients with CVD, who were on the outpatient treatment at the Kharkiv City Clinical Hospital No. 27, were used. The following methods were used: frequency analysis of drug prescriptions, statistical analysis and generalization of information.
Results. During the frequency analysis it was found that within the framework of the “Available medicines” program the drug Enalapril, 20 mg, No. 20, was the leader among drug prescriptions – 526 (6.70 %), and Magnikor, 75 mg, No. 100 – 870 (11.08 %) was the first among drugs that were not included in the list of this program. Calculation of the intensity of prescriptions (Кі) of drugs and their ranking into three groups showed that the drug Magnikor – Acetylsalicylic Acid (B01AC06, antiaggregants) was referred to the III group with a high Кі = 0.731.
Conclusions. Due to the high rate of prescribing drugs of the acetylsalicylic acid group, which has the proven effectiveness in preventing development of cardiovascular complications, such as myocardial infarctions and strokes, it becomes relevant to include this acid in the list of drugs to be reimbursed within the framework of the “Available medicines” program. Inclusion of acetylsalicylic acid, in particular the drug Magnikor, is a promising step in the expansion of the program and improvement of pharmaceutical care for patients with CVD.
Kornatskyi, V. M., Dorohoi, A. P., Adaricheva, Zh. H. (2016). Ukrainskyi kardiolohichnyi zhurnal, 3 (65), 72.
Elbarbary, M. (2010). Health Technology Assessment (HTA) in Cardiac Field. Journal of the Saudi Heart Association, 22 (2), 77–84. doi: 10.1016/j.jsha.2010.02.012.
Dostupni liky. Available at: http://moz.gov.ua/dostupni-liki.
Nemchenko, A. S., Kosiachenko, K. L., Nemchenko, O. A. (2012). Tsinoutvorennia na likarski zasoby [Pricing on medicinal products]. 2nd ed. Khаrkiv: Apostrof.
Kotvitska, A. A. Lobova, I. O. (2014). Proceedings of Menedzhment ta marketynh u skladi suchasnoi ekonomiky, nauky, osvity, praktyky: materialy II Mizhnar. nauk.-prakt. Internet-konf. (pp. 243-244). Kharkiv.
Mishchenko, O. Ya., Iakovlieva, L. V., Ostashko, V. F. (2016). Klinichna farmatsiia, 20 (4), 24-28.
Tolochko, V. M., Nemchenko, O. A. (2014). Proceedings of Farmakolohiia, fiziolohiia i patolohiia nyrok, sechovyvidnykh shliakhiv ta vodno-solovoho obminu: tezy dop. nauk.-prakt. konf. z mizhnar. uchastiu ta shkoloiu molodykh vchenykh. (pp. 103-105). Kharkiv.
Kanavos P., Schurer W., Vogler S. (2011). The Pharmaceutical Distribution Chain in the European Union: Structure and Impact on Pharmaceutical. Brussels, Belgium, 120. Available at: http://eprints.lse.ac.uk/51051/.
Shchuryk, M. V. (2009). Statystyka [Statistics]. Lviv: Mahnoliia, 545.
Kulikov, A. Yu., Kontsevaia, A. V. (2009). Kardiovaskuliarnaia terapiia i profilaktika, 9 (1), 51–57.
Seliverstova, D. V., Yevsina, O. V. (2014). Serdtse: zhurnal dlia praktikuiushchikh vrachei, 5 (79), 298–302.
Copyright (c) 2018 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).